Document is current

Any future updates will be listed below

Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study

Crossref DOI link: https://doi.org/10.1007/s10067-017-3700-z

Published Online: 2017-05-31

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark